Pricing Log in Create free account
Friday 6 November 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.

Revenue
+8.06%
EPS
+8.47%
Free cash flow
+69.5%
Total debt
+8.81%

Quarter to July 2026, against a year earlier

175.47 3.69 +2.15%
Market cap
$48.4B
P/E
33.8×
Fwd P/E
34.1×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Agilent Technologies, Inc. 10-K filed Dec 22, 2025

Fiscal year 2025 · Period ended Oct 31, 2025 · Filed · accepted 6:00 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business, against the 10-K filed Dec 20, 2024: 22 added · 19 removed · 61 modified; 5 with only figures updated; 4 moved without change

  1. Modified · Overview

    Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.